WHO Approves Phase 2/3 Trials for Two Ebola Bundibugyo Virus Vaccines
Audio narration · Coming soon
The World Health Organization has approved Phase 2/3 clinical trials for two new vaccine candidates targeting the Ebola Bundibugyo virus. This decision comes amid ongoing efforts to combat the virus affecting the Democratic region.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews